alphaveGUJTHEM₹430.00

Gujarat Themis Biosyn Limited

₹ CrorePeersRPGLIFE GUFICBIO ORCHPHARMA UNICHEMLAB FDC IOLCP MOREPENLAB INNOVACAPMcap ₹4,685 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY25 31/03/2025	FY26 31/03/2026
Non-current Assets
+ Property, Plant & Equipment	40.6	286.9
+ Capital Work-in-Progress	184.4	121.1
+ Other Intangibles	0.0	0.1
+ Intangibles under Development	0.2	0.0
+ Non-current Investments	0.0	2.8
+ Long-term Loans	0.8	0.8
+ Other Non-current Financial Assets	1.6	0.9
Non-current Financial Assets	2.4	4.5
+ Other Non-current Assets	21.8	2.0
Total Non-current Assets	249.3	414.6
Current Assets
+ Inventories	5.0	15.4
+ Trade Receivables	31.2	60.9
+ Cash & Cash Equivalents	11.7	3.1
+ Other Bank Balances	0.9	3.0
+ Short-term Loans	0.0	0.0
+ Other Current Financial Assets	1.0	0.3
Current Financial Assets	44.8	67.3
+ Other Current Assets	2.1	6.0
Total Current Assets	52.0	88.8
Total Assets	301.3	503.4
Equity
+ Equity Share Capital	10.9	10.9
+ Other Equity / Reserves	237.5	276.9
Equity — Owners of Parent	248.4	287.8
Total Equity	248.4	287.8
Liabilities
+ Borrowings — Non-current	29.6	128.1
+ Other Non-current Financial Liab	—	8.4
Non-current Financial Liabilities	29.6	136.5
+ Provisions — Non-current	0.8	0.0
+ Deferred Tax Liabilities	2.0	0.0
Non-current Liabilities	32.4	136.5
+ Borrowings — Current	0.3	31.8
+ Trade Payables	14.6	36.7
+ Other Current Financial Liab	4.9	7.2
Current Financial Liabilities	19.8	75.6
+ Provisions — Current	0.3	0.3
+ Current Tax Liabilities	0.0	0.1
+ Other Current Liabilities	0.5	3.1
Current Liabilities	20.6	79.2
Total Liabilities	52.9	215.7
Total Equity & Liabilities	301.3	503.4
Trade Payables — MSME split
+ Dues to Micro & Small — Current	0.6	0.4
+ Dues to Other Creditors — Current	14.1	36.3

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.